Been watching 3M (MMM) lately and there's something pretty significant brewing here that could reshape the whole dividend aristocrat narrative around this stock.

So here's the thing - 3M has held its dividend aristocrat status for over 60 years, consistently raising payouts to shareholders. That's actually impressive in this market. Right now it's yielding around 5.72%, which is honestly one of the juiciest yields in the industrial sector. But there's a massive shadow hanging over it.

The company is dealing with roughly 300,000 claims related to defective foam earplugs sold to U.S. military personnel. The settlement talks are already underway, and analysts are estimating this could cost 3M somewhere north of 10 billion dollars. On top of that, there's a whole other litigation mess - PFAS chemical contamination lawsuits from municipalities. That's potentially another 10 billion in settlements. Yeah, you read that right.

When you combine both of these, we're talking about a scenario where 3M might be forced to slash its dividend just to stay afloat. And that's the kicker - if they cut the dividend, they lose the dividend aristocrat designation. It's not just a label either; it affects how institutional investors view the stock.

Wolfe Research already slashed their price target to $92, and the consensus has turned pretty bearish. The payout ratio is currently healthy at 63%, but that math changes dramatically once these settlements hit the books.

Now, there's one potential lifeline - 3M is spinning off its healthcare business as a separate public company. They're looking to retain about 19.9% and could pull in over 3.2 billion from that deal. Plus, the healthcare unit is supposed to pay out a one-time dividend of 6.7 billion to the parent. That's real cash coming in.

But here's where it gets tricky - even with that cash injection, analysts don't think it'll be enough to cover both the litigation costs and maintain the current dividend level. RBC Capital's take is that post-spin-off, 3M becomes a smaller company with lower dividend payouts, and yeah, probably loses that dividend aristocrat crown.

The stock is down 14% year-to-date, and honestly, the litigation overhang is the main reason. If you're considering MMM for that dividend income, you might want to wait and see how these settlements actually play out. The dividend aristocrat status could be on borrowed time.